TENET HEALTHCARE CORP Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest
TENET HEALTHCARE CORP (THC) reported Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest of $932.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Shareholders' Equity
us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest · last filed 2026-07-29
- TENET HEALTHCARE CORP net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2026-06-30 was $932.00M, a 137.15% increase year-over-year.
- TENET HEALTHCARE CORP net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2026-03-31 was $795.00M, a 58.68% increase year-over-year.
- TENET HEALTHCARE CORP net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2025-09-30 was $448.00M, a 20.99% decline year-over-year.
- TENET HEALTHCARE CORP net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2025-06-30 was $393.00M, a 10.39% increase year-over-year.
- TENET HEALTHCARE CORP net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2025 was $1.83B, a 48.96% decline from fiscal 2024.
- TENET HEALTHCARE CORP net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2024 was $3.59B, a 280.00% increase from fiscal 2023.
- TENET HEALTHCARE CORP net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2023 was $945.00M, a 44.72% increase from fiscal 2022.
- TENET HEALTHCARE CORP net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2022 was $653.00M, a 42.72% decline from fiscal 2021.
| Period end | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 3 month as first filed | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 12 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $932.00M 10-Q · filed 2026-07-29 | $1.73B derived: sum of 2 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | $795.00M 10-Q · filed 2026-07-29 | |||||
| 2025-12-31 | $1.83B 10-K · filed 2026-02-17 | |||||
| 2025-09-30 | $448.00M 10-Q · filed 2025-10-28 | $841.00M derived: sum of 2 quarters · filed 2026-07-29 | $1.34B derived: sum of 3 quarters · filed 2026-07-29 | |||
| 2025-06-30 | $393.00M 10-Q · filed 2026-07-29 | $894.00M derived: sum of 2 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | $501.00M 10-Q · filed 2026-07-29 | |||||
| 2024-12-31 | $3.59B 10-K · filed 2026-02-17 | |||||
| 2024-09-30 | $567.00M 10-Q · filed 2025-10-28 | $923.00M derived: sum of 2 quarters · filed 2025-10-28 | $3.16B derived: sum of 3 quarters · filed 2025-10-28 | |||
| 2024-06-30 | $356.00M 10-Q · filed 2025-10-28 | $2.59B derived: sum of 2 quarters · filed 2025-10-28 | ||||
| 2024-03-31 | $2.23B 10-Q · filed 2025-10-28 | |||||
| 2023-12-31 | $945.00M 10-K · filed 2026-02-17 | |||||
| 2023-09-30 | $176.00M 10-Q · filed 2024-10-29 | $381.00M derived: sum of 2 quarters · filed 2024-10-29 | $598.00M derived: sum of 3 quarters · filed 2024-10-29 | |||
| 2023-06-30 | $205.00M 10-Q · filed 2024-10-29 | $422.00M derived: sum of 2 quarters · filed 2024-10-29 | ||||
| 2023-03-31 | $217.00M 10-Q · filed 2024-10-29 | |||||
| 2022-12-31 | $653.00M 10-K · filed 2025-02-18 | |||||
| 2022-09-30 | $194.00M 10-Q · filed 2023-10-30 | $290.00M derived: sum of 2 quarters · filed 2023-10-30 | $476.00M derived: sum of 3 quarters · filed 2023-10-30 | |||
| 2022-06-30 | $96.00M 10-Q · filed 2023-10-30 | $282.00M derived: sum of 2 quarters · filed 2023-10-30 | ||||
| 2022-03-31 | $186.00M 10-Q · filed 2023-10-30 | |||||
| 2021-12-31 | $1.14B 10-K · filed 2024-02-16 | |||||
| 2021-09-30 | $505.00M 10-Q · filed 2022-10-28 | $682.00M derived: sum of 2 quarters · filed 2022-10-28 | $823.00M derived: sum of 3 quarters · filed 2022-10-28 | |||
| 2021-06-30 | $177.00M 10-Q · filed 2022-10-28 | $318.00M derived: sum of 2 quarters · filed 2022-10-28 | ||||
| 2021-03-31 | $141.00M 10-Q · filed 2022-10-28 | |||||
| 2020-12-31 | $582.00M 10-K · filed 2023-02-21 | |||||
| 2020-09-30 | -$148.00M 10-Q · filed 2021-10-29 | -$25.00M derived: sum of 2 quarters · filed 2021-10-29 | $100.00M derived: sum of 3 quarters · filed 2021-10-29 | |||
| 2020-06-30 | $123.00M 10-Q · filed 2021-10-29 | $248.00M derived: sum of 2 quarters · filed 2021-10-29 | ||||
| 2020-03-31 | $125.00M 10-Q · filed 2021-10-29 | |||||
| 2019-12-31 | -$21.00M 10-K · filed 2022-02-18 | -$38.00M 10-K · filed 2020-02-24 | ||||
| 2019-09-30 | -$181.00M 10-Q · filed 2020-10-30 | -$187.00M 10-Q · filed 2019-11-04 | -$108.00M derived: sum of 2 quarters · filed 2020-10-30 | -$83.00M derived: sum of 3 quarters · filed 2020-10-30 | ||
| 2019-06-30 | $73.00M 10-Q · filed 2020-10-30 | $64.00M 10-Q · filed 2019-08-05 | $98.00M derived: sum of 2 quarters · filed 2020-10-30 | |||
| 2019-03-31 | $25.00M 10-Q · filed 2020-10-30 | $18.00M 10-Q · filed 2019-04-29 | ||||
| 2018-12-31 | $269.00M 10-K · filed 2021-02-19 | $276.00M 10-K · filed 2019-02-25 | ||||
| 2018-09-30 | $31.00M 10-Q · filed 2019-11-04 | $99.00M derived: sum of 2 quarters · filed 2019-11-04 | $229.00M derived: sum of 3 quarters · filed 2019-11-04 | $46.00M derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2018-06-30 | $68.00M 10-Q · filed 2019-11-04 | $198.00M 10-Q · filed 2018-08-06 | $15.00M derived: sum of 3 quarters · filed 2020-02-24 | -$324.00M derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2018-03-31 | $130.00M 10-Q · filed 2019-11-04 | -$53.00M derived: sum of 2 quarters · filed 2020-02-24 | -$392.00M derived: sum of 3 quarters · filed 2020-02-24 | -$412.00M derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2017-12-31 | -$183.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | -$522.00M derived: sum of 2 quarters · filed 2020-02-24 | -$542.00M derived: sum of 3 quarters · filed 2020-02-24 | -$559.00M 10-K · filed 2020-02-24 | ||
| 2017-09-30 | -$339.00M 10-Q · filed 2018-11-05 | -$359.00M derived: sum of 2 quarters · filed 2018-11-05 | -$376.00M 10-Q · filed 2017-11-07 | -$413.00M derived: sum of 4 quarters · filed 2019-02-25 | ||
| 2017-06-30 | -$20.00M 10-Q · filed 2018-11-05 | -$37.00M 10-Q · filed 2018-08-06 | -$74.00M derived: sum of 3 quarters · filed 2019-02-25 | -$48.00M derived: sum of 4 quarters · filed 2019-02-25 | ||
| 2017-03-31 | -$17.00M 10-Q · filed 2018-11-05 | -$54.00M derived: sum of 2 quarters · filed 2019-02-25 | -$28.00M derived: sum of 3 quarters · filed 2019-02-25 | -$25.00M derived: sum of 4 quarters · filed 2019-02-25 | ||
| 2016-12-31 | -$37.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | -$11.00M derived: sum of 2 quarters · filed 2019-02-25 | -$8.00M derived: sum of 3 quarters · filed 2019-02-25 | -$54.00M 10-K · filed 2019-02-25 | ||
| 2016-09-30 | $26.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $29.00M derived: sum of 2 quarters · filed 2017-11-07 | -$17.00M 10-Q · filed 2017-11-07 | -$95.00M derived: sum of 4 quarters · filed 2018-02-26 | ||
| 2016-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$43.00M 10-Q · filed 2017-08-07 | -$121.00M derived: sum of 3 quarters · filed 2018-02-26 | -$137.00M derived: sum of 4 quarters · filed 2018-02-26 | ||
| 2016-03-31 | -$46.00M 10-Q · filed 2017-05-01 | -$124.00M derived: sum of 2 quarters · filed 2018-02-26 | -$140.00M derived: sum of 3 quarters · filed 2018-02-26 | -$189.00M derived: sum of 4 quarters · filed 2018-02-26 | ||
| 2015-12-31 | -$78.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | -$94.00M derived: sum of 2 quarters · filed 2018-02-26 | -$143.00M derived: sum of 3 quarters · filed 2018-02-26 | -$88.00M 10-K · filed 2018-02-26 | ||
| 2015-09-30 | -$16.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | -$65.00M derived: sum of 2 quarters · filed 2016-10-31 | -$10.00M 10-Q · filed 2016-10-31 | $62.00M derived: sum of 4 quarters · filed 2017-02-27 | ||
| 2015-06-30 | -$49.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $6.00M 10-Q · filed 2016-08-01 | $78.00M derived: sum of 3 quarters · filed 2017-02-27 | $94.00M derived: sum of 4 quarters · filed 2017-02-27 | ||
| 2015-03-31 | $55.00M 10-Q · filed 2016-05-02 | $127.00M derived: sum of 2 quarters · filed 2017-02-27 | $143.00M derived: sum of 3 quarters · filed 2017-02-27 | $125.00M derived: sum of 4 quarters · filed 2017-02-27 | ||
| 2014-12-31 | $72.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $88.00M derived: sum of 2 quarters · filed 2017-02-27 | $70.00M derived: sum of 3 quarters · filed 2017-02-27 | $43.00M 10-K · filed 2017-02-27 | ||
| 2014-09-30 | $16.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | -$2.00M derived: sum of 2 quarters · filed 2015-11-02 | -$29.00M 10-Q · filed 2015-11-02 | -$45.00M derived: sum of 4 quarters · filed 2016-02-22 | ||
| 2014-06-30 | -$18.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03 | -$45.00M 10-Q · filed 2015-08-03 | -$61.00M derived: sum of 3 quarters · filed 2016-02-22 | |||
| 2014-03-31 | -$27.00M 10-Q · filed 2015-05-04 | -$43.00M derived: sum of 2 quarters · filed 2016-02-22 | ||||
| 2013-12-31 | -$16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-22 | -$113.00M 10-K · filed 2016-02-22 | ||||
| 2013-09-30 | -$97.00M 10-Q · filed 2014-11-03 | |||||
| 2012-12-31 | $130.00M 10-K · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Surgery Partners, Inc. (SGRY) | United States | $1.860B | -24.80 |
| Ardent Health, Inc. (ARDT) | United States | $1.478B | 17.91 |
| COMMUNITY HEALTH SYSTEMS INC (CYH) | United States | $0.405B | 1.87 |
| HCA Healthcare, Inc. (HCA) | United States | $93.934B | 15.49 |